Format
Sort by
Items per page

Send to

Choose Destination

Best matches for imiquimod:

Reviewing the use of imiquimod for molluscum contagiosum. DiBiagio JR et al. Dermatol Online J. (2018)

Genital warts treatment: Beyond imiquimod. Yuan J et al. Hum Vaccin Immunother. (2018)

A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas. Kamath P et al. Clin Drug Investig. (2018)

Search results

Items: 1 to 20 of 3570

1.

Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.

Nadeem A, Ahmad SF, Al-Harbi NO, El-Sherbeeny AM, Alasmari AF, Alanazi WA, Alasmari F, Ibrahim KE, Al-Harbi MM, Bakheet SA, Attia SM.

Int Immunopharmacol. 2020 Jan 23;80:106215. doi: 10.1016/j.intimp.2020.106215. [Epub ahead of print]

PMID:
31982823
2.

'Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial'; a critical appraisal.

Olabi B, Tasker F, Williams HC.

Br J Dermatol. 2020 Jan 24. doi: 10.1111/bjd.18891. [Epub ahead of print]

PMID:
31977075
3.

Immunological effects of adjuvants in subsets of antigen presenting cells of cancer patients undergoing chemotherapy.

Mauriello A, Manolio C, Cavalluzzo B, Avallone A, Borrelli M, Morabito A, Iovine E, Chambery A, Russo R, Tornesello ML, Buonaguro FM, Tagliamonte M, Buonaguro L.

J Transl Med. 2020 Jan 23;18(1):34. doi: 10.1186/s12967-020-02218-x.

4.

Effects of toll-like receptor-7 agonists on feeding behavior, voluntary activity, cloacal temperature and crop emptying in chicks.

Tachibana T, Takeda K, Khan SI, Makino R, Cline MA.

Br Poult Sci. 2020 Jan 24. doi: 10.1080/00071668.2020.1720907. [Epub ahead of print]

PMID:
31973574
5.

Human Orf: An Under-recognized Entity.

Santiago L, Oliveira D, Cardoso JC, Figueired A.

Acta Dermatovenerol Croat. 2019 Dec;27(4):280-281.

PMID:
31969245
6.

A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs imiquimod vs ingenol mebutate vs methylaminolevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.

Jansen MHE, Kessels JPHM, Merks I, Nelemans PJ, Kelleners-Smeets NWJ, Mosterd K, Essers BAB.

Br J Dermatol. 2020 Jan 21. doi: 10.1111/bjd.18884. [Epub ahead of print]

PMID:
31961446
7.

Successful treatment of chromoblastomycosis caused by Fonsecaea pedrosoi using imiquimod.

Belda W Jr, Criado PR, Passero LFD.

J Dermatol. 2020 Jan 21. doi: 10.1111/1346-8138.15225. [Epub ahead of print]

PMID:
31960479
8.

Retinol and vitamin A metabolites accumulate through RBP4 and STRA6 changes in a psoriasis murine model.

Wang HM, Wu C, Jiang YY, Wang WM, Jin HZ.

Nutr Metab (Lond). 2020 Jan 13;17:5. doi: 10.1186/s12986-019-0423-y. eCollection 2020.

9.

Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice.

Li L, Fu L, Zhou P, Lu Y, Zhang L, Wang W, Nie J, Zhang D, Liu Y, Wu B, Chen T.

Arch Dermatol Res. 2020 Jan 18. doi: 10.1007/s00403-019-02030-8. [Epub ahead of print]

PMID:
31953572
10.

Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates epidermal keratinization under psoriatic skin inflammation.

Ogawa T, Ishitsuka Y, Inoue S, Nakamura Y, Saito A, Okiyama N, Fujisawa Y, Furuta JI, Watanabe R, Fujimoto M.

Am J Pathol. 2020 Jan 14. pii: S0002-9440(20)30002-X. doi: 10.1016/j.ajpath.2019.10.022. [Epub ahead of print]

PMID:
31953037
11.

Negative regulation of dendritic cell activation in psoriasis mediated via CD100-Plexin-B2.

Xiao C, Luo Y, Zhang C, Zhu Z, Yang L, Qiao H, Fu M, Wang G, Yao X, Li W.

J Pathol. 2020 Jan 14. doi: 10.1002/path.5383. [Epub ahead of print]

PMID:
31943215
12.

The proton pump inhibitor, lansoprazole, prevents the development of non-traumatic osteonecrosis of the femoral head: an experimental and prospective clinical trial.

Kosukegawa I, Okazaki S, Yamamoto M, Nagoya S, Suzuki C, Shimizu J, Takahashi H, Yamashita T.

Eur J Orthop Surg Traumatol. 2020 Jan 14. doi: 10.1007/s00590-020-02622-5. [Epub ahead of print]

PMID:
31938894
13.

Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α.

Martin P, Palmer G, Rodriguez E, Palomo J, Lemeille S, Goldstein J, Gabay C.

J Immunol. 2020 Jan 13. pii: ji1901074. doi: 10.4049/jimmunol.1901074. [Epub ahead of print]

PMID:
31932497
14.

Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation.

Thatikonda S, Pooladanda V, Sigalapalli DK, Godugu C.

Cell Death Dis. 2020 Jan 10;11(1):21. doi: 10.1038/s41419-019-2212-y.

15.

Anti-HPV Nanoemulsified-Imiquimod: A New and Potent Formulation to Treat Cervical Cancer.

Frank LA, Gazzi RP, Mello PA, Chaves P, Peña F, Beck RCR, Buffon A, Pohlmann AR, Guterres SS.

AAPS PharmSciTech. 2020 Jan 6;21(2):54. doi: 10.1208/s12249-019-1558-x.

PMID:
31907712
16.

Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity.

Chodisetti SB, Fike AJ, Domeier PP, Singh H, Choi NM, Corradetti C, Kawasawa YI, Cooper TK, Caricchio R, Rahman ZSM.

J Immunol. 2020 Jan 3. pii: ji1901175. doi: 10.4049/jimmunol.1901175. [Epub ahead of print]

PMID:
31900342
17.

Aryl Hydrocarbon Receptor in Cutaneous Vascular Endothelial Cells Restricts Psoriasis Development by Negatively Regulating Neutrophil Recruitment.

Zhu Z, Chen J, Lin Y, Zhang C, Li W, Qiao H, Fu M, Dang E, Wang G.

J Invest Dermatol. 2019 Dec 30. pii: S0022-202X(19)33569-9. doi: 10.1016/j.jid.2019.11.022. [Epub ahead of print]

PMID:
31899186
18.

PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization.

Li L, Zhang HY, Zhong XQ, Lu Y, Wei J, Li L, Chen H, Lu C, Han L.

Life Sci. 2019 Dec 27;243:117231. doi: 10.1016/j.lfs.2019.117231. [Epub ahead of print]

PMID:
31887296
19.

Tussilagonone Ameliorates Psoriatic Features in Keratinocytes and Imiquimod-Induced Psoriasis-Like Lesions in Mice via NRF2 Activation.

Lee J, Song K, Hiebert P, Werner S, Kim TG, Kim YS.

J Invest Dermatol. 2019 Dec 23. pii: S0022-202X(19)33494-3. doi: 10.1016/j.jid.2019.12.008. [Epub ahead of print]

PMID:
31877316
20.

Liraglutide improved inflammation via mediating IL-23/Th-17 pathway in obese diabetic mice with psoriasiform skin.

Chen P, Lin L, Xu X, Zhang Z, Cai W, Shao Z, Chen S, Chen X, Weng Q.

J Dermatolog Treat. 2020 Jan 3:1-7. doi: 10.1080/09546634.2019.1708853. [Epub ahead of print]

PMID:
31868553

Supplemental Content

Loading ...
Support Center